NewsBenzingaCartesian Therapeutics Presents Additional Retreatment Data Of Its Lead Investigational Asset, Descartes-08, In Patients With Generalized MG, During MGFA Scientific Session Of 2026 AANEM Annual Meeting Cartesian Therapeutics Presents Additional Retreatment Data Of Its Lead Investigational Asset, Descartes-08, In Patients With Generalized MG, During MGFA Scientific Session Of 2026 AANEM Annual Meeting Benzinga 2026.09.29 11:32 (GMT+0) Open on Benzinga Other news Stock Market: Will S&P 500 Open Up or Down Today? Mark Zuckerberg Opens Meta's Massive Muse Spark AI Model, Says It Runs Great on Apple's New Mac Studios Thanks to John Ternus Elizabeth Warren Calls Bank of America’s $1.2 Billion Fine a ‘Slap-on-the-Wrist,’ Points to $30 Billion Profit Filecoin adjusts reward mechanism and launches new products Why Is NextTrip (NTRP) Stock Falling After Hours? ‘Putin Humiliates Trump Every Chance He Gets:’ Anthony Scaramucci Slams Russian Diesel Deal, Ukraine Energy Ceasefire
Mark Zuckerberg Opens Meta's Massive Muse Spark AI Model, Says It Runs Great on Apple's New Mac Studios Thanks to John Ternus
Elizabeth Warren Calls Bank of America’s $1.2 Billion Fine a ‘Slap-on-the-Wrist,’ Points to $30 Billion Profit
‘Putin Humiliates Trump Every Chance He Gets:’ Anthony Scaramucci Slams Russian Diesel Deal, Ukraine Energy Ceasefire
